Actively Recruiting
Culturally Adapted Cognitive Behavior Therapy for Individuals At Risk of First Episode Psychosis
Led by Pakistan Institute of Living and Learning · Updated on 2026-04-13
90
Participants Needed
2
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Young people constitute nearly half of Pakistan's population and are highly vulnerable to risk factors for mental illness, including poverty, inequality, abuse, and violence. Estimates suggest that 19-34% of children and adolescents experience emotional or behavioural disorders, though this is likely underestimated. In recent years, research has focused on those at imminent risk of developing serious conditions such as first episode psychosis. The concept of an At-Risk Mental State (ARMS) has highlighted the urgent need for interventions that address current symptoms, improve functioning, and reduce transition to psychosis. Up to 80% of young people with ARMS have another diagnosable condition, and almost half show poor psychosocial outcomes even six years after initial help-seeking. Evidence demonstrates that early identification and treatment can delay or prevent psychosis, including severe and enduring illnesses like schizophrenia. Cognitive Behaviour Therapy (CBT) is among the most effective evidence-based approaches for this group. However, existing evidence comes largely from high-income countries, raising concerns about cultural applicability in low-resource settings. This study will culturally adapt and field test a manualised CBT intervention for young people at risk of first episode psychosis. To our knowledge, this is the first such study in a low-income country. Findings will inform scalable, culturally relevant interventions for Pakistan and similar contexts.
CONDITIONS
Official Title
Culturally Adapted Cognitive Behavior Therapy for Individuals At Risk of First Episode Psychosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female help-seeking individual aged 16-35 years
- Score 6 or above on PQ-16
- Meet the at risk of first episode psychosis criteria using CAARMS Operationalized Intake Criteria based on vulnerability, attenuated psychosis, or brief limited intermittent psychotic symptoms groups
- Assessed as competent to provide informed consent
- Provide written informed consent
You will not qualify if you...
- Temporary resident unlikely to be available for follow-up
- Unable to engage, participate, or respond to research questionnaires
- History of psychotic illness (treated or untreated)
- Previous treatment with an antipsychotic or mood-stabilising agent
- Active substance abuse (except nicotine or caffeine) or dependence within the last three months according to DSM-V criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Commuity/Schools/Colleges
Karachi, Sindh, Pakistan
Actively Recruiting
2
Karwan e Hayat
Karachi, Sindh, Pakistan
Actively Recruiting
Research Team
A
Ameer B Khoso, PhD Fellow
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here